Business
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
ALISO VIEJO, Calif., April 06, 2026--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today that its technologies will be featured in various scientific programming at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held April 10-13, 2026 in Washington, D.C. Glaukos will be exhibiting onsite at booth #407.
About this update from Glaukos Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2774,"height":518,"url":"https://media.zenfs.com/en/business-wire.com/49ea933d7e424173b554729a3009b4b9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Nb35E2KIi7TQK7nlweiPUQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE3OQ--/https://media.zenfs.com/en/business-wire.com/49ea933d7e424173b554729a3009b4b9","width":960,"height":179},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/nn5zBDtUwKAm_Xr3iBmrag--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00NDg-/https://media.zenfs.com/en/business-wire.com/49ea933d7e424173b554729a3009b4b9","width":1200,"height":224}},"lazy":false},{"type":"text","content":"ALISO VIEJO, Calif., April 06, 2026--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today that its technologies will be featured in various scientific programming at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held April 10-13, 2026 in Washington, D.C. Glaukos will be exhibiting onsite at booth #407.","length":516,"tagName":"p"},{"type":"text","content":"In addition, Glaukos is sponsoring an educational symposium in conjunction with ASCRS and EyeWorld entitled "Introducing Epioxa™, the first and only FDA-approved, epithelium-on, oxygen-enriched corneal cross-linking treatment," on Friday, April 10, 2026, from 12:00-1:00 p.m. ET in Room 102 AB at the Walter E. Washington Convention Center. The faculty includes Brandon D. Ayres, MD (moderator); Kenneth A. Beckman, MD; Maanasa Indaram, MD; and Matt Jensen, MBA. Go here for more information and to register.","length":518,"tagName":"p"},{"type":"text","content":"Key Glaucoma and Corneal Health Presentations (in ET):","length":54,"tagName":"p"},{"type":"text","content":"Saturday, April 11, 2026","length":24,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"1:40-1:45 p.m., Arkadiy Yadgarov, MD12-Month Outcomes of Standalone Third-Generation Trabecular Micro-Bypass Stents in Eyes with Open-Angle Glaucoma","length":149,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":149,"olType":false},{"type":"list","items"...